ZOWIE Unveils First European Esports Lab
ZOWIE is taking a truly scientific approach to helping European pros reach their peak. This is not just about equipment—it's about understanding performance at its deepest level.
"With the ZOWIE Sports Science Lab, we're bringing scientific methodology to help European pro players unlock their full potential,' said Jay Wu, President of BenQ Europe B.V. 'Every design is grounded in real-world player data and expert insights, reflecting our dedication to performance-driven product innovation and the future of esports.'
Leveraging motion capture and electromyography (EMG), the lab analyzes player interactions with mice, collecting data on ergonomics, joint angles, movement speed, and muscle activity. This enables personalized mouse recommendations tailored to individual playstyles and game types, letting players optimize their training based on fatigue data to maintain peak performance under prolonged competitive pressure.
Player-Centric Design, Informed by Data
Since the launch of the iconic EC series mouse, co-developed in 2010 with Swedish esports legend Emil 'HeatoN' Christensen, ZOWIE has remained committed to evolving its products through real-world player feedback. With the new Sports Science Lab, ZOWIE can assess how various mouse models align with individual gameplay styles across titles like CS2, VALORANT, Fortnite, and Apex Legends, enabling precise equipment recommendations that maximize player potential.
The lab also evaluates performance before and after fatigue sets in, helping players identify issues like reduced finger stability or imprecise deceleration control, and adapt their training accordingly. Continuous collaboration with esports athletes throughout the testing process ensures that every product generation reflects the evolving demands of actual competition.
Sports Science in Action: ZOWIE Mouse Design
Sports science insights play a central role in shaping ZOWIE's mouse designs. The U series, for instance, was designed for fast-paced games like Valorant, Fortnite, and Apex Legends, featuring a lightweight wireless build and improved claw grip feel to enhance agility and endurance.
Similarly, the EC3 goes beyond simply scaling down from EC2 to incorporate deeper sports science insights, with a restructured design that adjusts finger joint angles and side button placement to reduce fatigue during rapid clicking and avoid accidental presses. Testing has shown that these refinements help minimize strain in the wrist flexor muscles during repeated click-intensive tasks.
The DW series, ZOWIE's latest symmetrical wireless mouse, was also developed based on real-world gameplay needs and professional player testing data. Designed to support a variety of grip styles, each model in the DW series offers distinct gameplay advantages. For example, DW-FK variants excel during repeated micro-adjustments, providing greater precision and long-term comfort in FPS games that require strong aiming.
Looking Ahead: Expanding Innovation Through Research
ZOWIE has long been devoted to innovating esports technology, holding numerous patents and continually evolving its product design philosophy. The launch of the new European Sports Science Lab marks a milestone in ZOWIE's product innovation journey.
With the European esports market experiencing exponential growth – projected to reach USD 4.3 billion by 2033 with a CAGR of 11.04% from 2025 to 2033 1 – ZOWIE is committed to expanding its research efforts to deliver tailored gear and training recommendations that adapt to the evolving demands of players.
About ZOWIE / BenQ Corporation
Established in 2008, ZOWIE is a top esports brand for professional players, focusing on player-centric design and dedicated to providing esports gear for professional FPS players. In 2015, ZOWIE joined BenQ Corporation, combining its expertise with BenQ's robust R&D resources and leading panel manufacturing capabilities. ZOWIE remains committed to driving excellence in product design through scientific research. With 70% of professional players using ZOWIE products, the brand continues to successfully deliver serious gear technology to global players. For more information, please visit: https://zowie.benq.eu/en-eu/mouse.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
MetricStream Recognized as a Leader in Green Quadrant: GRC Software 2025 Report
SAN JOSE, Calif., August 19, 2025--(BUSINESS WIRE)--MetricStream, the global leader in AI-first governance, risk, and compliance (GRC) solutions, today announced it has been recognized as a Leader in the Green Quadrant: GRC Software 2025 report by independent research firm Verdantix. According to the report, MetricStream delivers comprehensive GRC solutions with AI-enhanced risk visibility and compliance automation. MetricStream was noted for its broad functionalities and ability to handle high volumes of data, making it ideal for firms operating in regulated industries and those managing diverse risk domains at scale, as well as its strong capabilities in AI analytics and automation, feature richness, and extensive configuration options. MetricStream also scored high on the following capabilities: regulatory change management, audit management, governance and policy management, and AI, Natural Language Search, Large Language Models, and Small Language Models. "We are thrilled to be recognized as a leader by Verdantix," said Manu Gopeendran, Senior Vice President, Strategy and Marketing, MetricStream. "This recognition reflects the strength of our AI-first strategy in helping organizations simplify GRC and amplifying strategic outcomes. It also affirms our commitment to deliver scalable, connected GRC solutions with advanced AI-enhanced analytics and automation that empower global enterprises to detect risks sooner, act faster, and drive continuous resilience." "MetricStream delivers comprehensive GRC solutions with AI-enhanced risk visibility and compliance automation. Our analysis finds that MetricStream offers strong capabilities in AI-enhanced analytics and automation by delivering a broad, end-to-end set of risk, compliance and audit capabilities. Its platform shines in AI-enhanced analytics and automation, leveraging machine learning (ML) models to prioritize control failures, detect emerging risk patterns and drive continuous monitoring," commented Katelyn Johnson, Senior Manager, Verdantix. Visit for more information and to read the full report. About Verdantix Verdantix is an independent research and advisory firm that serves a global client base consisting of the world's most innovative corporations, technology and services vendors, and investors. Our insights and analysis form a foundation of the most granular data available in the marketplaces we serve. This allows us to make highly accurate far-reaching forecasts and big-picture predictions that business leaders depend on when they are setting out to reach their most important goals. About MetricStream Inc. MetricStream simplifies Governance, Risk, and Compliance (GRC) with purpose-built AI-first Risk, Compliance, Audit, Cyber GRC, Third-party Risk, and Resilience products on a single low-code / no-code GRC cloud platform. Trusted by over 1 million GRC professionals across 35+ countries, our industry-specific products and AI agents help businesses successfully manage audits, avoid compliance violations and fines, reduce risk exposure, and strengthen resilience. MetricStream is headquartered in San Jose, California, with operations and offices around the globe. Learn more at Follow MetricStream on LinkedIn, Facebook, and X. View source version on Contacts Media Contact: Patricia A. McParlandVice President, Marketingpr@ Sign in to access your portfolio
Business Wire
23 minutes ago
- Business Wire
Sequencing.com Announces Strategic Partnership with PGxAI to Drive Affordable Healthcare Through Advanced Pharmacogenomics
PALO ALTO, Calif.--(BUSINESS WIRE)-- a biotech company offering the world's largest platform for whole genome sequencing and personalized health insights, announced a strategic partnership with PGxAI, a leader in AI-driven pharmacogenomics. This collaboration will transform the pharmacogenomics field by combining cutting-edge genomic insights with real-world healthcare applications, ultimately enhancing patient outcomes and reducing adverse drug reactions. Announces Strategic Partnership with PGxAI to Drive Affordable Healthcare Through Advanced Pharmacogenomics Share As part of this initiative, PGxAI will roll out a suite of pharmacogenomic reports on that provide personalized drug implications based on an individual's genomic data. They directly address a critical healthcare need — reducing adverse drug reaction incidences, a leading cause of unnecessary healthcare costs and patient harm. The reports cover over 730 drugs and 40 genes — offering up to five times the coverage of competitors. 'Adverse drug reactions account for over $150 billion in excess healthcare costs annually in the U.S., ' said Allan Gobbs, PGxAI Executive Chairman and Co-Founder. ' Studies indicate that pharmacogenomics can reduce these incidents by 30%, representing a significant opportunity to optimize healthcare costs and make treatments more affordable and effective.' Dr. Brandon Colby, Founder and CEO, added, 'The demand for pharmacogenomic testing is rapidly growing. PGxAI's scientific rigor and comprehensive data coverage provide unmatched value to our customers, further driving the precision health movement.' 'More than 99% of individuals carry clinically relevant drug-gene variations, ' said Dr. Mike Zack, PGxAI CEO and Co-Founder. 'Leveraging this information enables safer, more effective treatment regimens, making precision pharmacogenomics an immediate reality for modern healthcare.' PGxAI's reports seamlessly integrate with major reporting formats from clinically actionable consumer genetic testing services. These integrations allow users to effortlessly upload their genetic data, unlocking actionable insights linked to FDA guidelines and leading pharmacogenomics consortiums. These reports also represent new revenue opportunities for laboratories working with genomic data. Zack emphasized, 'Our reports are plug-and-play for genomic labs, offering new revenue streams while delivering measurable benefits for patients.' Learn more about this partnership at About Founded in 2017 by Dr. Brandon Colby and based in Los Angeles, (Sequencing) is a biotech company offering the world's largest platform for whole genome sequencing and personalized health insights. While most DNA tests obtain less than 0.1% of DNA data, Sequencing DNA test bundles allow users to obtain 100% of their DNA sequencing data, and the company offers the most private DNA sequencing test on the market. Led by US medical doctors, geneticists, bioinformatics experts, and software developers, Sequencing helps users make proactive decisions with their healthcare provider and genetic counselors around rare diseases, cancer risks, autoimmune disorders, cardiovascular health, and much more. Learn more at LinkedIn, Instagram, TikTok, X, and Facebook. About PGxAI Launched in 2023, Palo Alto‑based PGxAI stands at the forefront of pharmacogenomics, leveraging AI and real-world data to drive innovation in precision medicine. The platform employs proprietary algorithms to personalize drug selection, dosage, and interaction management. PGxAI is led by a team of scientists, AI experts and serial entrepreneurs, including CEO and сo-founder Dr. Mike Zack, MD, PhD, a UCSF pharmacogenomics expert, and executive chairman and сo-founder Allan Gobbs, a seasoned Life Sciences VC. The advisory board includes Dr. Russ Altman of Stanford University and executives from Thermo Fisher, GE Healthcare, and Tempus AI. Backed by New York-based ATEM Capital and in strategic partnership with InterSystems, PGxAI seeks to address the critical need for tailored, effective therapies in healthcare, and set new standards for precision medicine.
Business Wire
23 minutes ago
- Business Wire
Viant Integrates with Wurl to Enable Scene-Level CTV Targeting and Measurement
IRVINE, Calif.--(BUSINESS WIRE)-- Viant Technology Inc. (NASDAQ: DSP), a leader in CTV and AI-powered programmatic advertising, today announced a new integration with Wurl to become the first Demand-Side Platform (DSP) to deliver scene-level contextual intelligence across Connected Television (CTV). This advancement is powered by IRIS_ID and enriched with Wurl BrandDiscovery's unique streaming signals and proprietary scene identification. With this innovation, advertisers gain the power to align messaging with on-screen context in real time, driving stronger engagement and outcomes. "The partnership with Wurl helps fulfill our mission to drive meaningful outcomes for our advertisers, and across the CTV landscape by addressing persistent challenges like fragmented targeting, limited measurement and lack of content transparency." Share This breakthrough is further enhanced by Viant's new Open Real Time Bidding (oRTB) integration with Wurl, unlocking premium Free Ad-Supported Streaming TV (FAST) inventory from top publishers. This partnership marks the first time Wurl's BrandDiscovery-enabled supply is available via direct oRTB in a DSP, aligning with Viant's supply path optimization initiatives by streamlining access to premium inventory. By combining this supply with Viant's Household ID and identity graph, which provides 95% of coverage of U.S. adults 18+, advertisers achieve greater reach, relevance, and efficiency in the fastest-growing digital advertising channel: CTV. 'As the first DSP to offer scene-level targeting and measurement capabilities, we are powering a new generation of privacy-safe, contextually relevant advertising that benefits the entire ecosystem,' said Tom Wolfe, SVP of Business Development at Viant. 'The partnership with Wurl helps fulfill our mission to drive meaningful outcomes for our advertisers, and across the CTV landscape by addressing persistent challenges like fragmented targeting, limited measurement and lack of content transparency.' Through its integration with Wurl's proprietary BrandDiscovery segments, which classify each scene's emotional tone and thematic context, are now assigned IRIS_IDs at the scene level. With every Wurl impression IRIS-enabled, advertisers gain a new level of precision, aligning creative with narrative moments that drive stronger engagement and results. These signals are fully actionable in the Viant DSP via the company's newly launched IRIS-enabled™ Content Report and Pre-bid Targeting solution. Advertisers using the Viant DSP can now: Target and activate across scene-level emotional and contextual categories Access Wurl's premium FAST inventory programmatically via oRTB Discover top-performing scenes through the IRIS-enabled™ Content Report Measure and optimize performance with Viant's Advanced Reporting tools 'Wurl's mission includes unlocking greater value for both publishers and advertisers in the streaming ecosystem,' said Ria Madrid, VP of Advertising Partnerships at Wurl. 'With BrandDiscovery and IRIS IDs enabled across the Wurl footprint and fully integrated into Viant's DSP, a biddable contextual solution is now activated at unbelievable scale. Advertisers can reach streaming audiences while also aligning their creative with relevant content. Contextual relevance has been proven to drive results – better campaign performance and ROAS for advertisers, and incremental revenue for publishers.' ABOUT VIANT Viant Technology Inc. (NASDAQ: DSP) is a leader in AI-powered programmatic advertising, dedicated to driving innovation in digital marketing. Viant's omnichannel platform built for CTV allows marketers to plan, execute and measure their campaigns with unmatched precision and efficiency. With the launch of ViantAI, Viant is building the future of fully autonomous advertising solutions, empowering advertisers to achieve their boldest goals. Viant was recently awarded Best Demand-Side Platform by MarTech Breakthrough, Great Place to Work ® certification and received the Business Intelligence Group's AI Excellence Award. Learn more at ABOUT WURL Wurl is a leader in the streaming TV industry, developing innovative technologies for the delivery of content and ads on TV. The company supports publishers, streamers, and advertisers in growing viewership, maximizing revenue, and strengthening brand value. Wurl, LLC is owned by AppLovin Corporation (NASDAQ: APP). For more information, visit
